Affiliation:
1. N.N. Blokhin National Medical Research Center of Oncology
Abstract
Hepatocellular carcinoma is the fifth most common cancer worldwide and the approaches to treatmentdiffer due to the stage of the disease. According to BCLC classification, B stage patients are recommendedto be underwent transarterial chemoembolization. However, BCLC B integrates patients with differentintrahepatic tumor burden and with different liver deterioration. There are many staging classifications thatdetermine the treatment and survival rates due to heterogeneity of this patient cohort. The aim of this studyis to review the existing ones and to describe their prognostic value.
Publisher
Non-profit partnership Society of Interventional Oncoradiologists
Reference22 articles.
1. Fitzmaurice C, Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level results from the global burden of disease study 2015. JAMA Oncol. 2017;3(12):1683-91. DOI: 10.1001/jamaoncol.2017.3055.
2. Tang A, Hallouch O, Chernyak V, Kamaya A, Sirlin CB. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis. In: Abdominal Radiology. Vol. 43, Springer New York LLC. 2018:13-25. DOI: 10.1007/s00261-017- 1209.
3. Ghouri YA, Mian I, Rowe JH. Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis. Journal of Carcinogenesis. 2017;16:1-8. DOI: 10.4103/jcar.JCar_9_16.
4. Galle PR, Forner A, Llovet JM, Mazzaferro V, Piscaglia F, Raoul J-L, et al. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma [Internet]. 2018 [cited 2020 May 23]. DOI: 10.1016/j.jhep.2018.03.019.
5. Benson AB, Abbott DE, Abrams TA, Anaya DA, Anders R, Brown D, et al. NCCN Guidelines Version 5.2020 Hepatobiliary Cancers [Internet]. 2020.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献